Beit Jala Pharmaceutical Company announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was JOD 4.495 million compared to JOD 3.824 million a year ago. Net income was JOD 181,593 compared to JOD 309,803 a year ago. Basic earnings per share from continuing operations was JOD 0.026 compared to JOD 0.042 a year ago.